Report
Valens Research

UAFRS vs As Reported Weekly Highlights - Asia - 2020 02 07

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for 300003:CHN, VIPS, and 7564:JPN.
Underlyings
Lepu Medical Technology (Beijing) Co. Ltd. Class A

Lepu Medical Technology (Beijing) Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of cardiovascular related medical equipment, medicines and health products, as well as in the provision of related medical services. The Company's main products include stent systems, occluders, bulk drugs, clopidogrel sulfate, atorvastatin calcium tablets, pacemakers, in vitro diagnostic reagents and equipment and surgical instrument, among others. The Company distributes its products in domestic market and to overseas markets.

Vipshop Holdings Ltd Sponsored ADR

Workman Co. Ltd.

Workman is mainly engaged in the operation of specialty chain stores called "Workman" and the sale of clothing, work uniforms and work-related products. Co. mainly operates its business through franchised stores. Co. maintains total of 797 stores throughout Japan as of Mar 31 2017. Co.'s principal lines of products are inner ware, socks, hats, towel, apron, polo shirt, T-shirt, high neck shirt, work jumper, work pants, boiler suit, protective shoes, boot, safety shoes, thick cotton gloves, leather gloves, rain gear, and helmet, white coat for medical field and food industry, office uniform, and nursing clothes.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch